[Significance of ras mutations in pancreatic diseases].
Löhr
M
M
Klinik für Innere Medizin, Universität Rostock, Germany.
Liebe
S
S
Lowenfels
A B
AB
D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000473:pathology; D002908:Chronic Disease; D005500:Follow-Up Studies; D006801:Humans; D006965:Hyperplasia; D009154:Mutation / Q000235:genetics*; D010179:Pancreas / Q000473:pathology; D010183:Pancreatic Ducts / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology; D010195:Pancreatitis / Q000235:genetics* / Q000473:pathology; D016133:Polymerase Chain Reaction; D011230:Precancerous Conditions / Q000235:genetics* / Q000473:pathology; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*; D012307:Risk Factors
C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)
Die Bedeutung von ras-Mutationen bei Pankreaserkrankungen.